The Journal of Organic Chemistry
Note
Methyl N-(2,4-Dichlorophenyl)carbamate (4i).15 Reaction of
2,4-dichlorobenzamide 2i (14 mg, 0.075 mmol) according to the
general procedure afforded 13 mg (80%) of product 4i, isolated as
colorless needles (recrystallized from dichloromethane−hexane): mp
MHz, CDCl3) δ 4.46 (br s, 1H), 3.80 (m, 1H), 3.65 (s, 3H), 1.15 (d, J
= 6.5 Hz, 6H).
Methyl N-tert-Butylcarbamate (4u).21 Reaction of trimethyla-
cetamide 2u (15 mg, 0.15 mmol) according to the general procedure
67.6−68.3 °C (lit.15 mp 58−62 °C); H NMR (500 MHz, CDCl3) δ
1
1
afforded 14 mg (72%) of product 4u, isolated as a colorless oil: H
NMR (500 MHz, CDCl3) δ 4.60 (br s, 1H), 3.62 (s, 3H), 1.32 (s,
8.13 (d, J = 9 Hz, 1H), 7.36 (d, J = 3 Hz, 1H), 7.25 (dd, J = 9, 3 Hz,
1H), 7.09 (br s, 1H), 3.81 (s, 3H).
9H).
Methyl N-Cyclohexylcarbamate (4v).7c Reaction of cyclo-
hexanecarboxamide 2v (10 mg, 0.075 mmol) according to the general
procedure afforded 10 mg (85%) of product 4v, isolated as colorless
needles (recrystallized from dichloromethane−hexane): mp 74.6−75.2
°C (lit.7c mp 73.5−74.5 °C); IR (KBr) cm−1 3346, 2934, 1695, 1538,
Methyl N-(4-Bromophenyl)carbamate (4j).16 Reaction of p-
bromobenzamide 2j (15 mg, 0.075 mmol) according to the general
procedure afforded 17 mg (98%) of product 4j, isolated as a white
solid (recrystallized from dichloromethane−hexane: mp 125.1−125.7
°C; 1H NMR (500 MHz, CDCl3) δ 7.41 (d, J = 8.8 Hz, 2H), 7.28 (d, J
= 8.8 Hz, 2H), 6.58 (brs, 1H), 3.78 (s, 3H).
1
1229; H NMR (500 MHz, CDCl3): δ 4.53 (br s, 1H), 3.65 (s, 3H),
Methyl N-(4-Trifluoromethylphenyl)carbamate (4k).17 Reac-
tion of p-trifluoromethylbenzamide 2k (14 mg, 0.075 mmol)
according to the general procedure afforded 14 mg (85%) of product
4k, isolated as colorless needles (recrystallized from dichloro-
3.48 (br s, 1H), 1.98−1.86 (m, 2H), 1.75−1.65 (m, 2H), 1.64−1.56
(m, 1H), 1.40−1.28 (m, 2H), 1.22−1.06 (m, 3H).
Methyl N-(1-Adamantanyl)carbamate (4w).7c Reaction of 1-
adamantanecarboxamide 2w (13 mg, 0.075 mmol) according to the
general procedure afforded 13 mg (83%) of product 4w, isolated as
colorless needles (recrystallized from dichloromethane−hexane): mp
118.4−118.9 °C (lit.7c mp 118−120 °C); 1H NMR (500 MHz,
CDCl3) δ 4.51 (br s, 1H), 3.61 (s, 3H), 2.08 (s, 3H), 1.93 (s, 6H),
1.67 (s, 6H).
methane−hexane): mp 128.3−129 °C (lit.17 mp 129−130 °C); H
1
NMR (500 MHz, CDCl3) δ 7.57 (d, J = 8.5 Hz, 2H), 7.50 (d, J = 8.5
Hz, 2H), 6.74 (br s, 1H), 3.80 (s, 3H).
Methyl N-(4-Nitrophenyl)carbamate (4l).17 Reaction of p-
nitrobenzamide 2l (12 mg, 0.075 mmol) according to the general
procedure afforded 11 mg (75%) of product 4l, isolated as yellow
needles (recrystallized from dichloromethane−hexane): mp 177.2−
178 °C (lit.18 mp 176−177 °C); IR (KBr) cm−1 3391, 1740, 1595,
1508, 1326, 1219; 1H NMR (500 MHz, CDCl3) δ 8.21 (d, J = 7.8 Hz,
2H), 7.56 (d, J = 7.8 Hz, 2H), 6.93 (br s, 1H), 3.83 (s, 3H).
Methyl N-Benzylcarbamate (4n).7c Reaction of 2-phenyl-
acetamide 2n (10 mg, 0.075 mmol) according to the general
procedure afforded 12 mg (97%) of product 4n, isolated as colorless
needles (recrystallized from dichloromethane−hexane): mp 62.2−62.9
°C (lit.7c mp 63−65 °C); 1H NMR (500 MHz, CDCl3) δ 7.37 (t, J =
7.8 Hz, 2H), 7.31−7.25 (m, 3H), 4.98 (br s, 1H), 4.37 (d, J = 5.5 Hz,
2H), 3.70 (s, 3H).
p-Isocyanatotoluene (3a). N-(4-Methylphenylsulfonyl)-
iminophenyl-λ3-iodane 1 (34 mg, 0.09 mmol) was added to a solution
of p-toluamide 2a (10 mg, 0.075 mmol) in dichloromethane (1.5 mL)
and stirred at room temperature for 0.5 h. After completion of the
reaction, the mixture was concentrated and separated by preparative
TLC (hexane−ethyl acetate = 2: 1) to afford 8 mg (80%) of p-
1
isocyanatotoluene 3a, isolated as a brown oil: H NMR (500 MHz,
CDCl3) δ 7.22 (d, J = 8.5 Hz, 2H), 7.14 (d, J = 8.5 Hz, 2H), 2.33 (s,
3H). The obtained product is identical to a commercially available
sample.
Isopropyl N-(4-Methylphenyl)carbamate (5a).22 Reaction of p-
toluamide 2a (10 mg, 0.075 mmol) according to the general procedure
with isopropanol instead of methanol afforded 13 mg (90%) of
Methyl N-(1-Phenylpropyl)carbamate (4o).19 Reaction of 2-
phenylbutanamide 2o (12 mg, 0.075 mmol) according to the general
procedure afforded 14 mg (97%) of product 4o, isolated as a light
1
product 5a, isolated as colorless oil; H NMR (500 MHz, CDCl3) δ
7.25 (d, J = 8.6 Hz, 2H), 7.10 (d, J = 8.6 Hz, 2H), 6.46 (br s, 1H), 5.00
(sept, J = 6.2 Hz, 1H), 1.29 (d, J = 6.2 Hz, 6H).
1
brown oil: H NMR (500 MHz, CDCl3) δ 7.35 (t, J = 7.5 Hz, 2H),
tert-Butyl N-(4-Methylphenyl)carbamate (5b).23 Reaction of p-
toluamide 2a (10 mg, 0.075 mmol) according to the general procedure
with 2-methyl-2-propanol instead of methanol afforded 11 mg (71%)
of product 5b, isolated as colorless needles (recrystallized from
dichloromethane−hexane): mp 85.4−86 °C (lit.23 mp 86 °C); 1H
NMR (500 MHz, CDCl3) δ 7.23 (d, J = 8 Hz, 2H), 7.09 (d, J = 8 Hz,
2H), 6.37 (br s, 1H), 2.29 (s, 3H), 1.51 (s, 9H).
7.32−7.28 (m, 3H), 5.11 (br s, 1H), 4.68−4.54 (m, 1H), 3.66 (s, 3H),
1.92−1.72 (m, 2H), 0.92 (t, J = 7.5 Hz, 3H).
Methyl N-(4-Methylbenzyl)carbamate (4p).7c Reaction of 2-(p-
tolyl)acetamide 2p (11 mg, 0.075 mmol) according to the general
procedure afforded 12 mg (91%) of product 4p, isolated as colorless
needles (recrystallized from dichloromethane−hexane): mp 71.5−72.2
°C (lit,7c mp 68−70 °C); 1H NMR (500 MHz, CDCl3) δ 7.18 (d, J =
7.5 Hz, 2H), 7.14 (d, J = 7.5 Hz, 2H), 4.92 (brs, 1H), 4.33 (d, J = 5.5
Hz, 2H), 3.70 (s, 3H), 2.34 (s, 3H).
p-Toluidine (5c).24 N-(4-Methylphenylsulfonyl)iminophenyl-λ3-
iodane 1 (67 mg, 0.18 mmol) was added to a solution of p-toluamide
2a (20 mg, 0.15 mmol) in dichloromethane (3 mL) and stirred at
room temperature for 0.5 h. Then 10% HCl (3 mL) was added and
the resulting reaction mixture stirred at 50 °C for 1 h. After
completion of the reaction, the mixture was extracted with
dichloromethane. The aqueous layer was treated with 20% NaOH,
and then the mixture was extracted with dichloromethane. The organic
layer was dried over anhydrous sodium sulfate, concentrated, and then
separated by preparative TLC (hexane−ethyl acetate, 3:1) to afford 14
mg (89%) of analytically pure p-toluidine 5c, isolated as a brown solid
(recrystallized from dichloromethane−hexane): mp 45.8−46.5 °C
Methyl N-(4-Methoxybenzyl)carbamate (4q).7c Reaction of 2-
(p-methoxyphenyl)acetamide 2q (12 mg, 0.075 mmol) according to
the general procedure afforded 13 mg (86%) of product 4q, isolated as
colorless needles (recrystallized from dichloromethane−hexane): mp
73−73.8 °C (lit.7c mp 73−74 °C); H NMR (500 MHz, CDCl3) δ
1
7.21 (d, J = 8.5 Hz, 2H), 6.86 (d, J = 8.5 Hz, 2H), 4.91 (br s, 1H), 4.30
(d, J = 6 Hz, 2H), 3.80 (s, 3H), 3.69 (s, 3H).
Methyl N-[(1-Naphthyl)methyl]carbamate (4r).7c Reaction of
1-naphthaleneacetamide 2r (14 mg, 0.075 mmol) according to the
general procedure afforded 16 mg (95%) of product 4r, isolated as
colorless needles (recrystallized from dichloromethane−hexane): mp
86.2−86.6 °C (lit.7c mp 84−86 °C); IR (KBr) cm−1 3304, 1696, 1547,
1262; 1H NMR (500 MHz, CDCl3): δ 8.03 (d, J = 8 Hz, 1H), 7.88 (d,
J = 8.5 Hz, 1H), 7.81 (d, J = 9 Hz, 1H), 7.58−7.48 (m, 2H), 7.47−7.40
(m, 2H), 4.97 (br s, 1H), 4.83 (d, J = 6 Hz, 2H), 3.71 (s, 3H).
Methyl N-Pentylcarbamate (4s).20 Reaction of hexanamide 2s
(9 mg, 0.075 mmol) according to the general procedure afforded 10
(lit.24 mp 41−44 °C); H NMR (500 MHz, CDCl3) δ 6.96 (d, J = 8
1
Hz, 2H), 6.61 (d, J = 8 Hz, 2H), 3.56 (br s, 2H), 2.28 (s, 3H).
ASSOCIATED CONTENT
■
S
* Supporting Information
Copies of NMR spectra for all compounds. This material is
1
mg (92%) of product 4s, isolated as a colorless oil: H NMR (500
MHz, CDCl3) δ 4.62 (br s, 1H), 3.66 (s, 3H), 3.22−3.06 (m, 2H),
1.49 (quint, J = 7 Hz, 2H), 1.38−1.24 (m, 4H), 0.90 (t, J = 7 Hz, 3H).
Methyl N-Isopropylcarbamate (4t).7c Reaction of isobutyramide
2t (13 mg, 0.15 mmol) according to the general procedure afforded 13
AUTHOR INFORMATION
■
Corresponding Author
1
mg (74%) of product 4t, isolated as a colorless oil: H NMR (500
2090
dx.doi.org/10.1021/jo300007c | J. Org. Chem. 2012, 77, 2087−2091